KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Interest Expenses (2022 - 2025)

Adaptive Biotechnologies' Interest Expenses history spans 4 years, with the latest figure at $2.9 million for Q2 2025.

  • For Q2 2025, Interest Expenses rose 9.35% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $5.9 million, down 49.46%, while the annual FY2025 figure was $11.8 million, 1.71% up from the prior year.
  • Interest Expenses for Q2 2025 was $2.9 million at Adaptive Biotechnologies, up from $2.9 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $3.7 million in Q3 2023 and bottomed at $653000.0 in Q3 2022.
  • The 4-year median for Interest Expenses is $3.0 million (2024), against an average of $2.9 million.
  • The largest annual shift saw Interest Expenses surged 459.26% in 2023 before it decreased 25.21% in 2024.
  • A 4-year view of Interest Expenses shows it stood at $653000.0 in 2022, then soared by 361.26% to $3.0 million in 2023, then decreased by 1.99% to $3.0 million in 2024, then fell by 0.14% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Interest Expenses are $2.9 million (Q2 2025), $2.9 million (Q1 2025), and $3.0 million (Q4 2024).